Curis
CRIS
#10972
Rank
C$0.95 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-79.29%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.22. In 2024 the company made an earnings per share (EPS) of C-$9.99 an increase over its 2023 EPS that were of C-$12.83.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-47.95%
2024C-$9.99-22.15%
2023C-$12.83-26.17%
2022C-$17.3822.3%
2021C-$14.21-25.37%
2020C-$19.04-30.93%
2019C-$27.57-2.02%
2018C-$28.14
2016C-$63.95-10%
2015C-$71.05138.1%
2014C-$29.8440%
2013C-$21.32-25%
2012C-$28.4266.67%
2011C-$17.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$5.06-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.51-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.45-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.53 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.97 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.00-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA